Home » Topics » Disease categories and therapies » Immune

Immune
RSS

NCI to lead phase II trial of Repligen's CTLA4-Ig

Sep. 28, 1999

New interferon inducers described by Sumitomo and Japan Energy

Sep. 27, 1999

Cantab reports positive phase I results for DISC HSV vaccine

Sep. 24, 1999

Cytokine production modulators identified as part of Japanese pharmaceutical collaboration

Sep. 23, 1999

FDA approves Rapamune for rejection prevention in renal transplantation

Sep. 17, 1999

Newly discovered metabolite of sinomenine with more potent immunosuppressive activity

Sep. 17, 1999

Seragen sublicenses daclizumab patents to Roche

Sep. 16, 1999

Interleukin Genetics applies for inflammatory gene patent

Sep. 15, 1999

Chiron seeks U.K. approval for meningitis vaccine

Sep. 14, 1999

Merck & Co. launches preservative-free HBV vaccine

Sep. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...